• About us
• Contact

Advertisement

Organisation › Details

Abingworth LLP

Abingworth is a leading transatlantic life sciences investment firm with over $2 billion under management. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top calibre management teams building world-class companies. Since 1973, Abingworth has invested in over 179 life science companies, leading to 46 M&As and 73 IPOs. Our therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston. *

 

	Start	2013-02-05 existent
	Group	Carlyle (Group)
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Haines, Timothy (Tim) (Abingworth 201507– Managing Partner joined 2005 before Astex CEO)
	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	38 Jermyn Street
	City	SW1Y 6DN London
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
	Annual sales	2,000,000,000 (capital under management (2022) 2022-04-11)
		* Document for »About Section«: Carlyle Group, The. (4/11/22). "Press Release: Carlyle Expands Leading Healthcare Franchise with Agreement to Acquire Life Sciences Investment Firm Abingworth". New York, NY.
		Record changed: 2026-05-11

Advertisement

More documents for Carlyle (Group)

• [1] Carlyle Group, The. (4/11/22). "Press Release: Carlyle Expands Leading Healthcare Franchise with Agreement to Acquire Life Sciences Investment Firm Abingworth". New York, NY....
• [2] Glycomine, Inc.. (12/17/21). "Press Release: Glycomine Closes $68 Million Series B to Advance into Clinical Trials a Novel Treatment for PMM2-CDG, a Rare Glycosylation Disease". San Carlos, CA....
• [3] Inova Software SAS. (7/1/21). "Press Release: Carlyle Partners with Inova. Growth Equity Transaction to Support Inova’s Ambition to Become the Leading Platform for Life Science Collaborations". Lyon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.